Skin Cancer after Ruxolitinib or Belumosudil. Reply

N Engl J Med. 2023 Sep 21;389(12):1155. doi: 10.1056/NEJMc2309427.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acetamides
  • Carcinoma, Squamous Cell*
  • Humans
  • Skin Neoplasms* / drug therapy

Substances

  • belumosudil
  • ruxolitinib
  • Acetamides